180 related articles for article (PubMed ID: 20577802)
1. A new transgenic mouse line for tetracycline inducible transgene expression in mature melanocytes and the melanocyte stem cells using the Dopachrome tautomerase promoter.
Woods SL; Bishop JM
Transgenic Res; 2011 Apr; 20(2):421-8. PubMed ID: 20577802
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a new, inducible transgenic mouse model with GFP expression in melanocytes and their precursors.
Joshi SS; Tandukar B; Castaneda M; Jiang S; Diwakar G; Hertzano RP; Hornyak TJ
Gene Expr Patterns; 2018 Jan; 27():76-84. PubMed ID: 29061525
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal Labeling of Melanocytes in Mice.
Preston S; Aras S; Zaidi MR
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29762513
[TBL] [Abstract][Full Text] [Related]
4. Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes.
Schwahn DJ; Timchenko NA; Shibahara S; Medrano EE
Pigment Cell Res; 2005 Jun; 18(3):203-13. PubMed ID: 15892717
[TBL] [Abstract][Full Text] [Related]
5. Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf.
Hornyak TJ; Hayes DJ; Chiu LY; Ziff EB
Mech Dev; 2001 Mar; 101(1-2):47-59. PubMed ID: 11231058
[TBL] [Abstract][Full Text] [Related]
6. DCT protects human melanocytic cells from UVR and ROS damage and increases cell viability.
Ainger SA; Yong XL; Wong SS; Skalamera D; Gabrielli B; Leonard JH; Sturm RA
Exp Dermatol; 2014 Dec; 23(12):916-21. PubMed ID: 25346513
[TBL] [Abstract][Full Text] [Related]
7. A genetically engineered mouse model with inducible GFP expression in melanocytes.
Zaidi MR; Hornyak TJ; Merlino G
Pigment Cell Melanoma Res; 2011 Apr; 24(2):393-4. PubMed ID: 21392368
[No Abstract] [Full Text] [Related]
8. Gene expression profiling of cultured human NF1 heterozygous (NF1+/-) melanocytes reveals downregulation of a transcriptional cis-regulatory network mediating activation of the melanocyte-specific dopachrome tautomerase (DCT) gene.
Boucneau J; De Schepper S; Vuylsteke M; Van Hummelen P; Naeyaert JM; Lambert J
Pigment Cell Res; 2005 Aug; 18(4):285-99. PubMed ID: 16033338
[TBL] [Abstract][Full Text] [Related]
9. B6-Dct-H2BGFP bitransgenic mice: A standardized mouse model for in vivo characterization of melanocyte development and stem cell differentiation.
Tandukar B; Kalapurakal E; Hornyak TJ
Pigment Cell Melanoma Res; 2021 Sep; 34(5):905-917. PubMed ID: 33544968
[TBL] [Abstract][Full Text] [Related]
10. Direct interaction of Sox10 with the promoter of murine Dopachrome Tautomerase (Dct) and synergistic activation of Dct expression with Mitf.
Jiao Z; Mollaaghababa R; Pavan WJ; Antonellis A; Green ED; Hornyak TJ
Pigment Cell Res; 2004 Aug; 17(4):352-62. PubMed ID: 15250937
[TBL] [Abstract][Full Text] [Related]
11. Melanoblasts' proper location and timed differentiation depend on Notch/RBP-J signaling in postnatal hair follicles.
Aubin-Houzelstein G; Djian-Zaouche J; Bernex F; Gadin S; Delmas V; Larue L; Panthier JJ
J Invest Dermatol; 2008 Nov; 128(11):2686-2695. PubMed ID: 18463680
[TBL] [Abstract][Full Text] [Related]
12. Value of dopachrome tautomerase detection in the assessment of melanocytic tumors.
Filimon A; Zurac SA; Milac AL; Sima LE; Petrescu SM; Negroiu G
Melanoma Res; 2014 Jun; 24(3):219-36. PubMed ID: 24709887
[TBL] [Abstract][Full Text] [Related]
13. Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors.
Ludwig A; Rehberg S; Wegner M
FEBS Lett; 2004 Jan; 556(1-3):236-44. PubMed ID: 14706856
[TBL] [Abstract][Full Text] [Related]
14. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
[TBL] [Abstract][Full Text] [Related]
15. Tyr-TGFalpha transgenic mice develop ocular melanocytic lesions.
Sutton R; Gordon-Thomson C; Cree IA; Mason RS; Moore GP
Melanoma Res; 2002 Oct; 12(5):435-9. PubMed ID: 12394184
[TBL] [Abstract][Full Text] [Related]
16. Melanocytes and pigmentation are affected in dopachrome tautomerase knockout mice.
Guyonneau L; Murisier F; Rossier A; Moulin A; Beermann F
Mol Cell Biol; 2004 Apr; 24(8):3396-403. PubMed ID: 15060160
[TBL] [Abstract][Full Text] [Related]
17. Altered melanocyte differentiation and retinal pigmented epithelium transdifferentiation induced by Mash1 expression in pigment cell precursors.
Lanning JL; Wallace JS; Zhang D; Diwakar G; Jiao Z; Hornyak TJ
J Invest Dermatol; 2005 Oct; 125(4):805-17. PubMed ID: 16185282
[TBL] [Abstract][Full Text] [Related]
18. Genomic localization of a Dct-LacZ transgene locus: a simple assay for transgene status.
Takemoto Y; Keighren M; Jackson IJ; Yamamoto H
Pigment Cell Res; 2006 Dec; 19(6):644-5. PubMed ID: 17083491
[No Abstract] [Full Text] [Related]
19. Tyrosinase-related protein 2 promoter targets transgene expression to ocular and neural crest-derived tissues.
Zhao S; Overbeek PA
Dev Biol; 1999 Dec; 216(1):154-63. PubMed ID: 10588869
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
